Daniel N. Swisher JR - 08 Aug 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr.
Issuer symbol
CORT
Transactions as of
08 Aug 2022
Transactions value $
-$435,723
Form type
4
Filing time
09 Aug 2022, 18:30:26 UTC
Previous filing
03 Jun 2022
Next filing
14 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $131K +20K $6.55* 20K 08 Aug 2022 Direct
transaction CORT Common Stock Tax liability -$131K -4.62K -23.08% $28.39 15.4K 08 Aug 2022 Direct F1
transaction CORT Common Stock Sale -$436K -15.4K -100% $28.32 0 08 Aug 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -20K -72.73% $0.00 7.5K 08 Aug 2022 Common Stock 20K $6.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price arising from a net (cashless) exercise of stock options that occurred on August 8, 2022. The options subject to the net exercise were to expire on June 18, 2025.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.30 to $28.38 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from Issuer upon request.
F3 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.